No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Jason Hollar New CFO of Cardinal Health

Editor: What To Know

  • Dave will partner with Jason Hollar in the coming weeks to ensure a smooth transition and as we continue to create value in a changing marketplace.
  • “With his deep executive experience, as well as his expertise leading in dynamic environments, Jason Hollar will be a strong partner to me and the rest of our team.
  • Kaufmann as a member of the company’s Executive Committee and will succeed Dave Evans, who will continue to serve as CFO of Cardinal Health through May 11.

As Tenneco’s executive vice president and chief financial officer, Jason Hollar was responsible for financial planning and analysis, accounting and reporting, tax, treasury and investor relations for the company.

Mr. Hollar joined Tenneco in June 2017 from Sears Holding Corporation, where he served as chief financial officer. Prior to Sears, Mr. Hollar worked with both Delphi Automotive and Navistar in a number of senior finance roles. He served as Delphi’s corporate controller and as vice president of finance for the company’s powertrain systems division, which also included oversight of the Europe, Middle East and Africa region. At Navistar, he held finance positions of increasing responsibility in the company’s engine group, South America operations and corporate financial planning and analysis.

Mr. Hollar received his Master of Business Administration from The University of Chicago and his bachelor’s degree in business from Indiana University.

“We are pleased to welcome Jason to the Cardinal Health family,” said Cardinal Health CEO Mike Kaufmann. “With his deep executive experience, as well as his expertise leading in dynamic environments, Jason Hollar will be a strong partner to me and the rest of our team. I’d like to thank Dave Evans for his exceptional contributions and leadership as our interim CFO. Dave will partner with Jason Hollar in the coming weeks to ensure a smooth transition and as we continue to create value in a changing marketplace.”

Mr. Hollar’s experience spans industries and geographies. In addition to serving as CFO of Tenneco and previously as CFO of Sears Holding Corporation, Mr. Hollar held senior finance roles at companies including Delphi and Navistar, demonstrating both breadth and depth across financial disciplines. He also managed regional operations around the globe and led multiple transformative initiatives to drive corporate strategies.

As Cardinal Health CFO, Jason Hollar will lead financial activities across the enterprise, including financial strategy, capital deployment, treasury, tax, investor relations, accounting and reporting. He will report to Mr. Kaufmann as a member of the company’s Executive Committee and will succeed Dave Evans, who will continue to serve as CFO of Cardinal Health through May 11.

I am excited to join the Cardinal Health team,” said Mr. Hollar. “I look forward to partnering with Mike, his leadership team and the Finance organization to advance the company’s strategic transformation at this pivotal time in healthcare.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy